SCHEMBL15412926

SCHEMBL15412926

CCOC(=O)c1cc(C)c(OC(=O)C2c3ccccc3Nc3ccccc32)c(C)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.48
ALDH1A1 P00352 3/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
CA1 P00915 2/20 0.40
CA2 P00918 2/20 0.40
CA12 O43570 1/20 0.38
CA7 P43166 1/20 0.38
CA9 Q16790 1/20 0.38
CA14 Q9ULX7 1/20 0.38
GAA P10253 3/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
KDM4E B2RXH2 2/20 0.38
HCRTR1 O43613 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
KDR P35968 1/20 0.38
DHFR P00374 1/20 0.38
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15412657 0.88 PPARA (0.44) MAPTALDH1A1L3MBTL1GAAMEN1
SCHEMBL15412609 0.81 MAPT (0.44) MAPTALDH1A1L3MBTL1CA1CA2
SCHEMBL27619302 0.79 ALDH1A1 (0.62) MAPTALDH1A1L3MBTL1GAAMEN1
SCHEMBL23685780 0.78 PPARA (0.41) MAPTALDH1A1L3MBTL1GAAMEN1
SCHEMBL27790888 0.70 CA12 (0.55) MAPTCA1CA2CA12CA7
SCHEMBL7218237 0.70 MAPT (0.74) MAPTALDH1A1L3MBTL1GAAMEN1
SCHEMBL23685927 0.69 MAPT (0.38) MAPTALDH1A1L3MBTL1GAAKDM4E
SCHEMBL6024348 0.68 EGFR (0.49) MAPTALDH1A1L3MBTL1GAAMEN1
SCHEMBL8985829 0.67 CA12 (0.58) ALDH1A1CA1CA2CA12CA7
SCHEMBL15413120 0.66 KMT2A (0.48) MAPTALDH1A1GAAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2872489-B1 SYNTHESIS OF ACRIDINIUM COMPOUNDS BY N-ALKYLATION OF ACRIDANS SIEMENS HEALTHCARE DIAGNOSTICS INC (US) 2016-12-21 EP disclosed
US-9512080-B2 Synthesis of acridinium compounds by N-alkylation of acridans SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) 2016-12-06 US disclosed
US-20150197491-A1 SYNTHESIS OF ACRIDINIUM COMPOUNDS BY N-ALKYLATION OF ACRIDANS SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) 2015-07-16 US disclosed
EP-2872489-A1 SYNTHESIS OF ACRIDINIUM COMPOUNDS BY N-ALKYLATION OF ACRIDANS Siemens Healthcare Diagnostics Inc. (US) 2015-05-20 EP disclosed
WO-2014011762-A1 SYNTHESIS OF ACRIDINIUM COMPOUNDS BY N-ALKYLATION OF ACRIDANS SIEMENS HEAL THCARE DIAGNOSTICS INC. (US) 2014-01-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150197491-A1 SYNTHESIS OF ACRIDINIUM COMPOUNDS BY N-ALKYLATION OF ACRIDANS ACR, MCL1, MGMT MAPT 4190/4885ALDH1A1 315/4885L3MBTL1 1392/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.